Gunnar Esiason, a cystic fibrosis advocate, explains why the Institute for Clinical and Economic Review’s model for determining drugs' value doesn't sit well with patients.
Gunnar Esiason, a cystic fibrosis advocate, explains why the Institute for Clinical and Economic Review’s model for determining drugs' value doesn't sit well with patients.